Awọn aṣeyọri wa:
Sorrento ti ni irin-ajo gigun lati ibẹrẹ irẹlẹ si wiwa biopharma oniruuru ati idagbasoke oogun iyipada igbesi aye.
2009
da
2013
Ti gba awọn ohun-ini Resiniferatoxin (RTX) nipasẹ gbigba ti Sherrington Pharmaceuticals Inc.
Awọn imọ-ẹrọ Isopọ Antibody Drug (ADC) ti a gba nipasẹ gbigba ti Concortis Biosystems Corp.
2014
PD-L1 ti o ni iwe-aṣẹ fun ọja China Greater si Lee's Pharm
2016
Ti ṣe agbekalẹ ImmuneOncia JV pẹlu Yuhan Pharmaceuticals
Ti gba ZTlido® nipasẹ poju igi ni Scilex Pharmaceuticals
Ti gba Bioserv Corporation fun awọn iṣẹ iṣelọpọ cGMP
Ti ṣe agbekalẹ Levena Suzhou Biopharma Co. LTD fun awọn iṣẹ Iṣọkan Oògùn Antibody (ADC)
2017
Ti gba Syeed Iwoye Oncolytic nipasẹ gbigba ti Virttu Biologics Limited
Ti ṣe Celularity pẹlu Celgene ati United Therapeutics
2018
Sofusa ti gba® Eto Ifijiṣẹ Lymphatic lati Kimberly-Clark
2019
Ti gba Semnur Pharmaceuticals
Ti ṣe agbekalẹ Scilex Holding lati ṣe imudara apapọ ti Scilex Pharma ati Semnur Pharma
2020
Abivertinib ti ni iwe-aṣẹ iyasọtọ lati ACEA Therapeutics fun gbogbo awọn itọkasi agbaye, laisi China
Syeed idanimọ HP-LAMP ni iwe-aṣẹ iyasọtọ lati Ile-ẹkọ giga Columbia fun wiwa awọn coronaviruses ati awọn ọlọjẹ aarun ayọkẹlẹ
Ti gba SmartPharm Therapeutics
2021
Ti gba ACEA Therapeutics
2022
Ti gba Virexhealth